Hypervitaminosis D Secondary to a
CELL/TISSUE SIGNALING – ENDOCRINE PATHWAYS
DISORDERS OF CALCIUM/PHOSPHATE METABOLISM
OTHER
PTH/VIT D/FGF23
THERAPEUTICS
Journal
JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
18
02
2023
revised:
15
05
2023
accepted:
06
06
2023
medline:
13
9
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
epublish
Résumé
Hypervitaminosis D as a cause of hypercalcemia may be due to vitamin D intoxication, granulomatous diseases, or abnormalities of vitamin D metabolism. The
Identifiants
pubmed: 37701149
doi: 10.1002/jbm4.10788
pii: JBM410788
pmc: PMC10494500
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e10788Informations de copyright
© 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Références
Calcif Tissue Int. 2020 Nov;107(5):524-528
pubmed: 32743688
J Clin Endocrinol Metab. 2015 Oct;100(10):E1343-52
pubmed: 26214117
Endocrinology. 2000 Jul;141(7):2658-66
pubmed: 10875271
Clin J Am Soc Nephrol. 2013 Apr;8(4):649-57
pubmed: 23293122
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):101-108
pubmed: 27060335
J Clin Endocrinol Metab. 2017 May 1;102(5):1440-1446
pubmed: 28324001
J Clin Endocrinol Metab. 2012 Mar;97(3):E423-7
pubmed: 22337913
J Clin Endocrinol Metab. 2014 Jul;99(7):2567-74
pubmed: 24670084
Hum Mutat. 2016 Jun;37(6):564-9
pubmed: 26931183
Ann Endocrinol (Paris). 2016 Oct;77(5):615-619
pubmed: 27378451
J Lipid Res. 2014 Jan;55(1):13-31
pubmed: 23564710
N Engl J Med. 2011 Aug 4;365(5):410-21
pubmed: 21675912
Eur J Endocrinol. 2021 Dec 10;186(2):137-149
pubmed: 34735369
Urolithiasis. 2017 Jun;45(3):291-294
pubmed: 27639704
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3159-e3166
pubmed: 35569070
Osteoporos Int. 2016 Oct;27(10):3121-5
pubmed: 27129455